# AN2 Therapeutics, Inc.: Form 8-K, filed Mar 28, 2024

- Company: [AN2 Therapeutics, Inc.](/companies/antx.md) (CIK 1880438)
- Form: 8-K
- Filed: 2024-03-28
- Accepted by EDGAR: Mar 28, 2024, 20:15 ET
- Period: 2024-03-28
- Accession: 0000950170-24-038055
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1880438/000095017024038055/antx-20240328.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1880438/000095017024038055/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1880438/000095017024038055/antx-20240328.htm

Filed Mar 28, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-038055. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.